Gerald Ullrich

Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney

From child to adult: An exploration of shifting family roles and responsibilities in managing physiotherapy for cystic fibrosis

Targeting microbial biofilms: current and prospective therapeutic strategies

Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: Formulation, characterisation and functionalisation with dornase alfa (DNase)

Cystic fibrosis

The Failing Heart — An Engine Out of Fuel

Pulmonary delivery of tobramycin-loaded nanostructured lipid carriers for Pseudomonas aeruginosa infections associated with cystic fibrosis

Cost of care and clinical condition in paediatric cystic fibrosis patients

Antibiotic resistance of bacterial biofilms

Atherosclerosis: inhibition of regression as therapeutic possibilities.

Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis

Microbiology and outcomes of community acquired pneumonia in non cystic-fibrosis bronchiectasis patients

What is an adequate sample size? Operationalising data saturation for theory-based interview studies

Lumacaftor/Ivacaftor: A Review in Cystic Fibrosis

Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction.

The antimicrobial activity of nanoparticles: present situation and prospects for the future

Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America

Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Coronary Plaque Disruption

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

Endothelial cells in physiology and in the pathophysiology of vascular disorders.

Molecular Mechanisms of Myocardial Remodeling

1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension

Antimicrobial Resistance in ESKAPE Pathogens

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.

European Cystic Fibrosis Society Standards of Care: Best Practice guidelines

Kostenvergleichsanalyse der stationären und ambulanten Intervalltherapie bei erwachsenen Mukoviszidosepatienten

The effect of ACE inhibition on myocardial energy metabolism

Transition of adult patients with cystic fibrosis from paediatric to adult care--the patients' perspective before and after start-up of an adult clinic.